Heidi Åhman

865 total citations
15 papers, 686 citations indexed

About

Heidi Åhman is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Heidi Åhman has authored 15 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Microbiology and 3 papers in Immunology. Recurrent topics in Heidi Åhman's work include Pneumonia and Respiratory Infections (13 papers), Respiratory viral infections research (11 papers) and Bacterial Infections and Vaccines (7 papers). Heidi Åhman is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Respiratory viral infections research (11 papers) and Bacterial Infections and Vaccines (7 papers). Heidi Åhman collaborates with scholars based in Finland, United States and Sweden. Heidi Åhman's co-authors include Helena Käyhty, Juhani Eskola, Odile Leroy, Terhi Kilpi, Jukka Jokinen, James E. Froeschle, Lennart Nilsson, P. Helena Mäkelä, Mikael Sörberg and Arja Vuorela and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Heidi Åhman

15 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Åhman Finland 11 620 399 83 48 45 15 686
Anu Soininen Finland 12 698 1.1× 336 0.8× 93 1.1× 40 0.8× 42 0.9× 18 762
Lindsey Ashton United Kingdom 16 929 1.5× 557 1.4× 127 1.5× 72 1.5× 41 0.9× 20 1.0k
Lucy Roalfe United Kingdom 11 574 0.9× 200 0.5× 86 1.0× 50 1.0× 49 1.1× 19 668
Pamela S. Palmer United States 6 331 0.5× 253 0.6× 35 0.4× 46 1.0× 35 0.8× 7 415
Eeva Pekkanen Finland 6 519 0.8× 440 1.1× 43 0.5× 66 1.4× 83 1.8× 7 656
Polly Burbidge United Kingdom 13 1.1k 1.7× 500 1.3× 112 1.3× 83 1.7× 57 1.3× 20 1.1k
Dorothee Kieninger Germany 11 680 1.1× 481 1.2× 86 1.0× 100 2.1× 42 0.9× 16 775
José García-Sicilia Spain 14 452 0.7× 248 0.6× 67 0.8× 63 1.3× 19 0.4× 21 519
C. Ethevenaux France 8 371 0.6× 262 0.7× 26 0.3× 56 1.2× 33 0.7× 11 452
Satu Rapola Finland 10 345 0.6× 196 0.5× 52 0.6× 35 0.7× 67 1.5× 13 402

Countries citing papers authored by Heidi Åhman

Since Specialization
Citations

This map shows the geographic impact of Heidi Åhman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Åhman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Åhman more than expected).

Fields of papers citing papers by Heidi Åhman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Åhman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Åhman. The network helps show where Heidi Åhman may publish in the future.

Co-authorship network of co-authors of Heidi Åhman

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Åhman. A scholar is included among the top collaborators of Heidi Åhman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Åhman. Heidi Åhman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Pugh, Sarah, Matt Wasserman, Mark H. Rozenbaum, et al.. (2020). Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis. Infectious Diseases and Therapy. 9(2). 305–324. 12 indexed citations
3.
Martikainen, Janne, et al.. (2014). Economic impact of 13‐valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions. Journal of Evaluation in Clinical Practice. 20(4). 333–341. 7 indexed citations
4.
Ekström, Nina, et al.. (2013). Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy. Clinical and Vaccine Immunology. 20(7). 1034–1040. 22 indexed citations
5.
Käyhty, Helena, et al.. (2005). Immunogenicity and Tolerability of a Heptavalent Pneumococcal Conjugate Vaccine Administered at 3, 5 and 12 Months of Age. The Pediatric Infectious Disease Journal. 24(2). 108–114. 81 indexed citations
6.
Jokinen, Jukka, et al.. (2004). Concentration of Antipneumococcal Antibodies as a Serological Correlate of Protection: An Application to Acute Otitis Media. The Journal of Infectious Diseases. 190(3). 545–550. 80 indexed citations
7.
Ekström, Nina, Heidi Åhman, Jukka Jokinen, et al.. (2004). Kinetics and Avidity of Antibodies Evoked by Heptavalent Pneumococcal Conjugate Vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infection and Immunity. 73(1). 369–377. 46 indexed citations
8.
Pussinen, Pirkko J., Kimmo Mattila, M. Vesanen, et al.. (2002). Antigenically Diverse Reference Strains and Autologous Strains ofActinobacillus actinomycetemcomitansAre Equally Efficient Antigens in Enzyme-Linked Immunosorbent Assay Analysis. Journal of Clinical Microbiology. 40(12). 4640–4645. 10 indexed citations
9.
Nurkka, Anu, Heidi Åhman, Mansour Yaïch, Juhani Eskola, & Helena Käyhty. (2001). Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. Vaccine. 20(1-2). 194–201. 35 indexed citations
10.
Käyhty, Helena & Heidi Åhman. (2001). Bridging Phase 2 and Phase 3 Pneumococcal Immunologic Data for Future Combination Vaccines. Clinical Infectious Diseases. 33(s4). S292–S298. 9 indexed citations
11.
Wuorimaa, Tomi, Ron Dagan, Juhani Eskola, et al.. (2001). Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers. The Pediatric Infectious Disease Journal. 20(3). 272–277. 46 indexed citations
12.
13.
14.
Åhman, Heidi, et al.. (1998). Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. The Pediatric Infectious Disease Journal. 17(3). 211–216. 108 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anu Soininen Breakdown of academic impact, for papers by Lindsey Ashton Breakdown of academic impact, for papers by Lucy Roalfe Breakdown of academic impact, for papers by Pamela S. Palmer Breakdown of academic impact, for papers by Eeva Pekkanen Breakdown of academic impact, for papers by Polly Burbidge Breakdown of academic impact, for papers by Dorothee Kieninger Breakdown of academic impact, for papers by José García-Sicilia Breakdown of academic impact, for papers by C. Ethevenaux Breakdown of academic impact, for papers by Satu Rapola
Rankless by CCL
2026